Your browser is no longer supported. Please, upgrade your browser.
Settings
OPNT Opiant Pharmaceuticals, Inc. daily Stock Chart
OPNT [NASD]
Opiant Pharmaceuticals, Inc.
Index- P/E4.45 EPS (ttm)2.08 Insider Own2.90% Shs Outstand4.23M Perf Week1.54%
Market Cap39.55M Forward P/E64.62 EPS next Y0.14 Insider Trans0.00% Shs Float3.87M Perf Month0.98%
Income11.60M PEG- EPS next Q-0.24 Inst Own31.40% Short Float0.24% Perf Quarter-19.51%
Sales39.40M P/S1.00 EPS this Y130.60% Inst Trans-7.95% Short Ratio0.13 Perf Half Y-25.69%
Book/sh8.00 P/B1.15 EPS next Y118.70% ROA31.30% Target Price- Perf Year-21.22%
Cash/sh7.52 P/C1.23 EPS next 5Y- ROE38.80% 52W Range8.05 - 18.23 Perf YTD-35.83%
Dividend- P/FCF- EPS past 5Y20.70% ROI32.30% 52W High-49.31% Beta0.58
Dividend %- Quick Ratio8.70 Sales past 5Y92.10% Gross Margin81.20% 52W Low14.78% ATR0.33
Employees21 Current Ratio8.70 Sales Q/Q-20.40% Oper. Margin28.10% RSI (14)50.56 Volatility3.92% 3.72%
OptionableNo Debt/Eq0.00 EPS Q/Q10.20% Profit Margin29.60% Rel Volume0.36 Prev Close9.21
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout0.00% Avg Volume72.48K Price9.24
Recom2.00 SMA20-0.84% SMA50-3.12% SMA200-21.87% Volume26,363 Change0.33%
May-29-19Initiated Northland Capital Outperform
Jul-23-20 04:01PM  
Jun-30-20 07:08PM  
Jun-08-20 04:14PM  
Jun-07-20 03:36AM  
Jun-05-20 09:37PM  
Jun-04-20 06:40PM  
May-26-20 04:05PM  
May-25-20 12:59PM  
May-21-20 04:05PM  
May-15-20 06:06AM  
May-12-20 04:05PM  
Apr-28-20 08:00AM  
Mar-26-20 02:57PM  
Mar-25-20 11:09PM  
Mar-09-20 07:15AM  
Mar-04-20 04:05PM  
Feb-24-20 04:01PM  
Jan-24-20 09:32AM  
Jan-06-20 04:26PM  
Jan-02-20 08:00AM  
Dec-12-19 04:05PM  
Dec-10-19 12:07PM  
Nov-24-19 04:25PM  
Nov-13-19 08:40AM  
07:10AM  
Nov-12-19 04:05PM  
Nov-05-19 08:00AM  
Oct-14-19 02:14PM  
Oct-10-19 08:00AM  
Sep-24-19 04:05PM  
Sep-17-19 08:00AM  
Sep-12-19 11:25AM  
Aug-27-19 04:30PM  
Aug-19-19 06:02PM  
Aug-13-19 10:10AM  
Aug-08-19 04:05PM  
Jul-30-19 04:30PM  
Jul-29-19 01:04PM  
Jul-23-19 08:00AM  
Jun-14-19 01:44PM  
May-25-19 07:25AM  
May-13-19 12:45PM  
May-09-19 04:05PM  
Apr-30-19 04:05PM  
Apr-28-19 09:53AM  
Apr-15-19 11:45AM  
Apr-12-19 10:13AM  
Apr-08-19 08:00AM  
Apr-03-19 08:00AM  
Apr-01-19 08:00AM  
Mar-28-19 08:00AM  
Mar-25-19 01:30PM  
Mar-21-19 04:05PM  
02:30PM  
07:51AM  
Mar-18-19 04:05PM  
Feb-21-19 04:05PM  
Feb-06-19 02:38PM  
Feb-01-19 11:30AM  
Jan-09-19 01:30PM  
Dec-26-18 08:00AM  
Dec-24-18 08:00AM  
Nov-20-18 11:13AM  
Nov-19-18 07:40AM  
Nov-16-18 11:56AM  
Nov-08-18 01:00PM  
Nov-07-18 04:05PM  
Nov-05-18 08:00AM  
Nov-01-18 08:00AM  
Oct-29-18 08:00AM  
Oct-22-18 08:00AM  
Oct-18-18 08:00AM  
Oct-04-18 12:15PM  
Sep-28-18 04:01PM  
Sep-26-18 08:00AM  
Sep-25-18 09:26AM  
08:30AM  
Sep-24-18 04:01PM  
Sep-21-18 08:51AM  
Sep-20-18 04:05PM  
Sep-14-18 12:04PM  
Sep-10-18 08:00AM  
Sep-04-18 08:00AM  
Aug-30-18 08:00AM  
Aug-29-18 03:00PM  
Aug-16-18 07:55AM  
Aug-10-18 11:45AM  
Aug-09-18 04:01PM  
02:30PM  
Aug-02-18 08:00AM  
Jun-25-18 04:05PM  
Jun-12-18 08:00AM  
Jun-04-18 04:05PM  
May-29-18 08:00AM  
May-25-18 07:45AM  
May-15-18 10:35AM  
May-08-18 04:05PM  
May-03-18 08:00AM  
Apr-20-18 07:30AM  
Apr-18-18 08:00AM  
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for opioid overdose; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.